Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli

International Journal of Antimicrobial Agents

Volumn 21, Issue 5, 2003, Pages 463-470

  Tsumura, Hiroaki ^a   Hiyama, Eiso ^b   Kodama, Takashi ^a   Sueda, Taijiro ^a   Yokoyama, Takashi ^b  

^a Hiroshima Municipal Funairi Hospital   (Japan)

^b Kousei General Hospital   (Japan)

Author keywords

Antimicrobial agent induced endotoxin; Gram negative bacillus infection; Tumour necrosis factor (TNF)

Indexed keywords

ANTIINFECTIVE AGENT; ENDOTOXIN; FLOMOXEF; GENTAMICIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; BLOOD CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; NONHUMAN; PERITONITIS; PLASMA; PRIORITY JOURNAL; RABBIT;

EID: 0242669987     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00037-2     Document Type: Article

References (25)

1. Holizheimer R.G. The significance of endotoxin release in experimental and clinical sepsis in surgical patients - evidence for antibiotic-induced endotoxin release. Infection. 26:1998;77-84.
2. Kirikae T., Nakano M., Morisson D.C. Antibiotic-induced endotoxin release from bacteria and its clinical significance - review. Microbiol. Immunol. 41:1997;285-294.
3. Trautmann M., Zick R., Rukavina T., Cross A.S., Marre R. Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics. J. Antimicrob. Chemother. 41:1998;163-169.
4. Crosby H.A., Bion J.F., Penn C.W., Elliott T.S.J. Antibiotic-induced release of endotoxin from bacteria in vitro. J. Med. Microbiol. 40:1994;23-30.
5. Prins J.M., van Deventer S.J., Kuijper E.J., Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob. Agents Chemother. 38:1994;1211-1218.
6. Jackson J., Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-biding protein (PBP) 2-spesific imipenem and PBP 3-spesific ceftazidime. J. Infect. Dis. 165:1992;1033-1041.
7. Yang R., Mark M., Mark M.R., et al. Tool-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature. 395:1998;284-288.
8. Prins J.M., Kuijper E.J., Mevissen M.L., Speelman P., van Deventer S.J. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immunol. 63:1995;2236-2242.
9. Dofferhoff A.S., Esselink M.T., de Vries Hospers H.G., et al. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J. Antimicrob. Chemother. 31:1993;373-384.
10. Periti P., Mazzei T. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. Int. J. Antimicrob. Agents. 12:1999;97-105.
11. Sawyer R.G., Adams R.B., May A.K., Rosenlof L.K., Pruett T.L. Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release. Arch. Surg. 128:1993;73-77.
12. Giamarellou-Bourboulis E.J., Perdios J., Lelekis M., Eoconomou E., Tsouroulas P., Giamarellou H. Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report. Int. J. Antimicrob. Agents. 11:1999;115-119.
13. Shenep J., Mogan K. Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J. Infect. Dis. 150:1984;380-388.
14. Harris R. Animproved chromogenic substrate endotoxin assay for clinical use. J. Clin. Pathol. 36:1983;1145-1149.
15. Tanaka S., Iwanaga S. Limulus test for detecting bacterial endotoxin. Methods Enzymol. 223:1993;358-364.
16. Meager A. Assays for TNF and related cytokines. J. Immunol. Methods. 116:1989;1-17.
17. Horrvath C. R-TNF increases pulmonary vascular permeability independent of neutrophils. Proc. Natl. Acad. Sci. USA. 85:1988;9219-9223.
18. Toumanen E., Gilbert K., Tomasz A. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob. Agents Chemother. 30:1986;659-663.
19. Hirata M., Shimomura Y., Yoshida M., Morgan J.P. Characterization of rabbit cationic protein (CAP 18) with lipopolysaccharide inhibitory activity. Infect. Immunol. 62:1994;1421-1426.
20. Appelmelk B., An Y., Thijs B., MacLaren D., de Graff J. Recombinant human bacterial permeability-increasing protein (rBP 123) is a universal lipopolysaccharide-binding ligand. Infect. Immunol. 62:1994;3564-3567.
21. Miyara T., Ishimine T., Saito A. Antibiotic-induced endotoxin release from Pseudomonas aeruginosa. Jpn. J. Chemother. 43:1995;351-356.
22. Holzheimer R.G., Hirte J.F., Reith B., Engelhardt W. Different endotoxin release and IL-6 plasma levels after antibitic administration in surgical intensive care patient. J. Endotoxin Res. 3:1996;261-267.
23. Simon D.M., Koenig G., Trenholme G.M. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J. Infect. Dis. 164:1991;800-802.
24. Leeson M.C., Morrison D.C. Induction of proinflammatory responses in human moncytes and soluble forms of lipopolysaccharide. Shock. 2:1994;235-245.
25. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A. Pro- and anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 181:2000;176-180.